Thyme Care Raises $97M in Series D Funding to Transform Cancer Care

Thyme Care, a leading value-based cancer care enabler, has secured a $97M Series D fundraise from a group of strategic investors, bringing its total capital raised to $275M. The investment was backed by current investors including CVS Health® Ventures, Foresite Capital, a16z Bio + Health, Concord Health Partners, Town Hall Ventures, AlleyCorp, and Frist Cressey Ventures, as well as new strategic investors such as Morgan Health, Humana, Texas Oncology, and Memorial Hermann Health System. Thyme Care's President and COO, Brad Diephuis, MD, emphasized the overwhelming support from investors across the oncology care delivery landscape, highlighting the shared accountability and impact that healthcare needs.

CEO and Co-Founder Robin Shah expressed the need for scalable models to address the complexities of cancer care. Since its establishment in 2020, Thyme Care has developed an integrated oncology infrastructure that focuses on reducing friction across the system and aligning incentives through partnerships with payers. The company works closely with over 1,000 oncologists nationwide to streamline administrative processes, support high-value drug choices, strengthen clinical collaboration, and integrate services such as palliative care and survivorship into its model.

Thyme Care's impact demonstrates systemic transformation across cost, experience, and provider efficiency. The company is now poised to leverage artificial intelligence as a critical accelerant in its model, aiming to target more breaking points in the oncology journey. The integration of AI seeks to reduce the cognitive load on care teams and provide real-time insights for more personalized and scalable cancer care.

Dan Mendelson, CEO of Morgan Health, acknowledged Thyme Care's ability to balance the needs of employers in providing high-quality, personalized cancer care while reducing costs. Vijay Patel, managing partner of CVS Health Ventures, emphasized Thyme Care's impact on improving the lives of people with cancer through technology, partnerships, and national scale. Thyme Care's mission is to transform the experience and outcomes for individuals living with cancer by collaborating with payers and providers to assume accountability for enhanced care quality, improved health outcomes, and reduced total cost of care.